by delphic-admin | Jan 23, 2024 | North America
The US Food and Drug Administration (FDA) has issued instructions for reporting serious adverse events under the Modernization of Cosmetics Regulation Act (MoCRA). From 29 December, the statute compels industry to notify the agency about any case linked to...
by delphic-admin | Jan 23, 2024 | North America
The US Food and Drug Administration (FDA) has launched an online system for industry to provide personal care product listings required by the Modernization of Cosmetics Regulation Act (MoCRA). Available on 18 December, the Cosmetics Direct portal was developed...
by delphic-admin | Jan 23, 2024 | North America
The FDA finalised draft guidance released in August on registration and listing requirements for cosmetic facilities and products. The guidance includes a new draft appendix meant to answer queries about the entities and items covered under MoCRA. For instance, it...
by delphic-admin | Dec 23, 2023 | North America
The Office of Environmental Health Hazard Assessment (OEHHA) is proposing to amend Article 6 on Clear and Reasonable Warnings Safe Harbour Methods and Content under Proposition 65. The proposal intends to make the Proposition 65 short-form safe harbour...
by delphic-admin | Dec 1, 2023 | North America
The US Food and Drug Administration (FDA) has deferred to mid-2024 the enforcement of product listing requirements imposed by the Modernization of Cosmetics Registration Act (MOCRA). Industry now has another half-year – until 1 July – to fulfill these duties under the...